Frankfurt - Delayed Quote EUR
Cidara Therapeutics, Inc. (20D0.F)
As of 8:03 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-124,780.00
-22,432.00
-28,473.00
-25,232.00
-54,411.00
--
Investing Cash Flow
-327.00
-505.00
-118.00
-41.00
-186.00
--
Financing Cash Flow
239,046.00
25,984.00
-951.00
44,597.00
37,278.00
--
End Cash Position
164,369.00
35,778.00
32,731.00
62,273.00
42,949.00
--
Income Tax Paid Supplemental Data
304.00
797.00
--
--
--
--
Interest Paid Supplemental Data
--
--
40.00
228.00
445.00
--
Capital Expenditure
-327.00
-505.00
-118.00
-41.00
-186.00
--
Issuance of Capital Stock
239,203.00
25,963.00
2,362.00
49,035.00
40,227.00
--
Repayment of Debt
-125.00
--
-2,593.00
-4,444.00
-2,963.00
--
Free Cash Flow
-125,107.00
-22,937.00
-28,591.00
-25,273.00
-54,597.00
--
12/31/2019 - 4/27/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0RK.F Exscientia plc
4.6000
-2.13%
J7Z.F Jazz Pharmaceuticals plc
103.75
-0.48%
430.F Terns Pharmaceuticals Inc
6.70
+0.75%
38I.F Intellia Therapeutics, Inc.
18.80
-2.67%
J90.F NurExone Biologic Inc.
0.3700
-2.12%
VX1.F Vertex Pharmaceuticals Incorporated
439.80
-0.61%
1VT.F Viking Therapeutics, Inc.
58.50
-1.18%
NRX.V NurExone Biologic Inc.
0.5400
0.00%
XBIO Xenetic Biosciences, Inc.
3.8100
+2.14%
TENX Tenax Therapeutics, Inc.
4.0669
+0.42%